Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MPL anticorps

MPL Reactivité: Humain WB, FACS, EIA Hôte: Souris Monoclonal 1H2 unconjugated
N° du produit ABIN1105749
  • Antigène Voir toutes MPL Anticorps
    MPL (Myeloproliferative Leukemia Virus Oncogene (MPL))
    Reactivité
    • 56
    • 26
    • 22
    • 1
    • 1
    Humain
    Hôte
    • 52
    • 7
    Souris
    Clonalité
    • 53
    • 6
    Monoclonal
    Conjugué
    • 20
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Cet anticorp MPL est non-conjugé
    Application
    • 38
    • 35
    • 15
    • 13
    • 13
    • 9
    • 6
    • 4
    • 4
    • 4
    • 2
    • 1
    Western Blotting (WB), Flow Cytometry (FACS), Enzyme Immunoassay (EIA)
    Specificité
    Recognizes MPL/CD110
    Réactivité croisée (Details)
    Species reactivity (tested):Human.
    Purification
    Purified
    Clone
    1H2
    Isotype
    IgG2b
    Top Product
    Discover our top product MPL Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1.0 mg/mL
    Buffer
    PBS, 0.05 % Sodium Azide, 0.5 % protein stabilizer
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • Antigène
    MPL (Myeloproliferative Leukemia Virus Oncogene (MPL))
    Autre désignation
    CD110 (MPL Produits)
    Synonymes
    anticorps C-MPL, anticorps CD110, anticorps MPLV, anticorps THCYT2, anticorps TPOR, anticorps TPO-R, anticorps c-mpl, anticorps c-mpl-I, anticorps c-mpl-II, anticorps hlb219, anticorps MPL, anticorps mpll, anticorps tpor, anticorps tpor.b, anticorps MPL proto-oncogene, thrombopoietin receptor, anticorps myeloproliferative leukemia virus oncogene, anticorps MPL, anticorps Mpl, anticorps mpl
    Sujet
    In 1990 an oncogene, v-mpl, was identified from the murine myeloproliferative leukemia virus that was capable of immortalizing bone marrow hematopoietic cells from different lineages. In 1992 the human homologue, named, c-mpl, was cloned. Sequence data revealed that c-mpl encoded a protein that was homologous with members of the hematopoietic receptor superfamily. Presence of anti-sense oligodeoxynucleotides of c-mpl inhibited megakaryocyte colony formation. The ligand for c-mpl, thrombopoietin, was cloned in 1994. Thrombopoietin was shown to be the major regulator of megakaryocytopoiesis and platelet formation. The protein encoded by the c-mpl gene, CD110, is a 635 amino acid transmembrane domain, with two extracellular cytokine receptor domains and two intracellular cytokine receptor box motifs . TPO-R deficient mice were severely thrombocytopenic, emphasizing the important role of CD110 and thrombopoietin in megakaryocyte and platelet formation. Upon binding of thrombopoietin CD110 is dimerized and the JAK family of non-receptor tyrosine kinases, as well as the STAT family, the MAPK family, the adaptor protein Shc and the receptors themselves become tyrosine phosphorylated.Synonyms: MPL, Myeloproliferative leukemia protein, TPO-R, TPOR
    Poids moléculaire
    71.2 kDa
    ID gène
    4352
    Pathways
    Signalistation JAK/STAT
Vous êtes ici:
Support technique